# Patterns of claims and determinants of claim rejections in Kuwait's National Health Insurance for Retirees (AFYA): a comprehensive analysis

**Authors:** Abdullah I. Alibrahim, Hisham Kelendar, Abdulaziz Alhenaidi

PMC · DOI: 10.3389/fpubh.2025.1606980 · Frontiers in Public Health · 2025-07-22

## TL;DR

This study analyzes health insurance claim rejections in Kuwait's AFYA program, finding that younger retirees, females, and dental services face higher rejection rates, while overall rejections have decreased over time.

## Contribution

The study identifies demographic and service-specific factors influencing claim rejections in a newly established national health insurance program.

## Key findings

- Younger retirees (under 40) had 1.82 times higher odds of claim denial compared to those aged 56–60.
- Dental services had a 2.28-fold increase in rejections compared to pharmaceutical claims.
- Claim rejection rates declined from 4.15% in 2017 to 3.42% by 2023.

## Abstract

Health insurance claim rejections can impose significant administrative and financial burdens, yet data from emerging national programs are limited. Kuwait's AFYA program, launched in 2016 for retirees, provides a valuable opportunity to study rejection patterns and identify the demographic and service-level factors that influence denial rates in a rapidly evolving high-income context.

This retrospective study analyzed 4.44 million AFYA claims from 2016 to 2023. Key variables included beneficiary characteristics (age group, sex), provider type, service category (dental, medical, pharmaceutical), claimed amount, and claim year. Logistic regression was employed to determine predictors of claim rejection, controlling for all the above factors. Sensitivity analyses excluded the top 1% of claimed amounts to check for robustness.

The overall rejection rate was 3.85%, lower than reported rates in some established systems. Younger retirees (under 40) had 1.82 times higher odds of claim denial than the reference group (56–60), and female beneficiaries had 1.21 times higher odds than males. Dental services were associated with a 2.28-fold increase in rejections relative to pharmaceutical claims. Laboratory claims, though relatively rare, showed exceptionally high rejection proportions. Rejection rates gradually declined over time, from 4.15% in 2017 to 3.42% by 2023. The most frequent reasons for denial involved uncovered services and insufficient clinical justification.

These findings underscore the critical role of clear coverage definitions, consistent coding, and effective administrative oversight in minimizing denials. Younger retirees, female beneficiaries, and certain service types (dental, laboratory) emerged as particularly vulnerable to rejections, indicating the need for targeted policy refinements. Notably, the downward trend in rejections suggests that AFYA has capacity for adaptive improvements over time.

By revealing pivotal factors that drive or mitigate claim rejections, this analysis offers practical guidance for policymakers and healthcare administrators. Standardized electronic forms, provider feedback loops and tighter coverage definitions could trim residual denials without restricting access. AFYA's experience offers transferable lessons for high-income countries seeking to expand private-sector purchasing while containing cost.

## Full-text entities

- **Diseases:** non-communicable diseases (MESH:D000073296), ID (MESH:C537985), weight loss (MESH:D015431), tumor (MESH:D009369), work injury (MESH:D000073397), diabetes (MESH:D003920), KD (MESH:D009080), congenital diseases (MESH:D030342), condition (MESH:D020763), death (MESH:D003643)
- **Chemicals:** AFYA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12321863/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12321863/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12321863/full.md

---
Source: https://tomesphere.com/paper/PMC12321863